Isolation of Human PBMCs from Whole Blood by Ficoll Gradient

Dillon Corvino

Isolation of peripheral blood mononuclear cells (PBMCs) from whole human blood using Ficoll density gradient centrifugation, followed by washing and optional cryopreservation.
Published

November 21, 2025

Protocol ID: HUM-BLD-PBMC-ISO
Version: v1.1
Author: Dillon Corvino

Purpose

This protocol describes the isolation of peripheral blood mononuclear cells (PBMCs) from whole human blood using Ficoll density gradient centrifugation. Whole blood is diluted with serum-free medium (R0), layered onto Ficoll, centrifuged to generate a mononuclear cell interface, and PBMCs are harvested, washed, and optionally cryopreserved in freezing medium.

Critical notes (read before starting)

  • Handle human blood and PBMCs as potentially infectious material under appropriate biosafety conditions (e.g. BSL2).
  • Carefully layer diluted blood onto Ficoll to avoid mixing; a sharp interface is essential for good yield and purity.
  • Use rcf (g) where possible rather than rpm; if rpm is used, ensure it corresponds to the correct g-force for your rotor.
  • Use low brake (or reduced deceleration) during the Ficoll spin to avoid disturbing the gradient.
  • Avoid aspirating Ficoll when harvesting the PBMC layer; take only the “fluffy” interface.
  • Keep cells at room temperature during the Ficoll separation and at room temperature or 4 °C during washes, as appropriate.
  • For cryopreservation, use controlled-rate freezing (e.g. Mr Frosty) and avoid leaving cells at room temperature with DMSO for prolonged periods.
Warning

Mixing of diluted blood with Ficoll or using high brake during the gradient centrifugation can collapse the interface and dramatically reduce PBMC yield and purity.

Tip

Prepare all R0 and R10 media, Ficoll tubes, and pre-labelled cryovials before starting. This simplifies handling once blood is collected and reduces the time PBMCs spend at room temperature.

Approximate timing

  • Setup and blood dilution: 10–15 min
  • Ficoll gradient and spin: 30 min
  • First PBMC wash: 15–20 min
  • Second wash and resuspension in R10: 15–20 min
  • Counting and freezing (if applicable): 20–30 min

Total approximate time: 1.5–2 hours.

Procedure

Step 1 – Tube labelling and blood dilution

  1. Label 50 mL conical tubes for each blood sample.
  2. For each sample, add whole blood to a 50 mL tube:
    • Transfer up to 17.5 mL whole blood per 50 mL tube.
  3. Dilute blood 1:2 with R0 medium (RPMI without FCS; BUF-R0-MED):
    • Add 17.5 mL R0 to 17.5 mL blood (total 35 mL).
    • If using less than 17.5 mL blood, top up to 35 mL with R0.
Note

Dilution with R0 reduces viscosity, improves layering on Ficoll, and can improve separation quality.

Step 2 – Ficoll layering and gradient centrifugation

  1. In a fresh 50 mL tube, add 10 mL Ficoll (density gradient medium).
  2. Using a 10 mL serological pipette, slowly overlay the 35 mL diluted blood onto the Ficoll:
    • Hold the Ficoll tube at a gentle angle.
    • Carefully dispense the diluted blood onto the Ficoll surface, avoiding mixing.
    • Maximum volume of diluted blood per tube: 35 mL.
  3. Prepare all Ficoll gradients required and ensure they are balanced.
  4. Centrifuge at 450 g (rcf) for 30 min at room temperature with:
    • Acceleration: 2
    • Deceleration: 1 (minimal brake)
  5. During centrifugation, prepare 10 mL tubes containing 3 mL R0 (2 tubes per Ficoll gradient) for PBMC collection.

Step 3 – Harvest of PBMC layer and first wash

  1. After centrifugation, identify:
    • Plasma / diluted medium layer on top.
    • A white, “fluffy” PBMC layer at the plasma/Ficoll interface.
    • Ficoll layer.
    • Pellet of erythrocytes and granulocytes at the bottom.
  2. Using a sterile transfer pipette, gently harvest the PBMC layer:
    • Carefully aspirate the interface and transfer to a 10 mL tube containing 3 mL R0.
    • Continue until the visible fluffy layer is removed.
  3. For each gradient, distribute the collected PBMCs across two 10 mL tubes (each with 3 mL R0).
  4. Centrifuge the 10 mL tubes at 400 g for 10 min at room temperature:
    • Acceleration: 9
    • Deceleration: 9
  5. Carefully remove and discard the supernatant without disturbing the cell pellets.

Step 4 – Second wash and resuspension in R10

  1. Resuspend each PBMC pellet in 3 mL R0.
  2. Combine two pellets into one tube and top up to 10 mL R0.
  3. Centrifuge at 400 g for 5 min at room temperature:
    • Acceleration: 9
    • Deceleration: 9
  4. Remove and discard the supernatant.
  5. Resuspend the pellet in 10 mL R10 (complete RPMI with 10 % FCS; BUF-R10-MED).
  6. If multiple gradients were processed for the same sample, combine their PBMC pellets into a single tube in R10.
  7. Centrifuge at 400 g for 5 min at room temperature.
  8. Remove and discard the supernatant.
  9. Resuspend the pellet in 1–10 mL R10, depending on pellet size and planned downstream use.

Step 5 – Counting and cryopreservation (optional)

  1. Mix the cell suspension gently and take a small aliquot for counting with trypan blue or an equivalent viability dye.
  2. Calculate the total number of viable PBMCs.
  3. For cryopreservation, aim for a final concentration of 10 × 10⁶ cells/mL per cryovial.

5.1 Preparation of 2× freezing medium (BUF-FREEZE-MIX)

  1. Prepare 2× freezing medium by mixing:
    • 7 mL R0
    • 1 mL FCS
    • 2 mL DMSO
      (Final: R0 + 10 % FCS + 20 % DMSO; 2× relative to standard 10 % DMSO freezing medium.)
  2. Keep the 2× freezing medium on ice and protected from light.

5.2 Adjust cell concentration and freeze

  1. Adjust PBMCs in R10 to 20 × 10⁶ cells/mL:
    • If only one cryovial is needed, pellet cells at 200 g for 5 min, remove supernatant, and resuspend so that the cell pellet is in 500 µL R10 (20 × 10⁶ cells/mL).
  2. Add an equal volume of 2× freezing medium (BUF-FREEZE-MIX) to the cells:
    • Final concentration: 10 × 10⁶ cells/mL in 10 % DMSO.
  3. Gently mix to avoid bubbles.
  4. Dispense 1 mL of cell suspension into pre-cooled cryovials, labelled with:
    • Patient name or anonymised ID.
    • Sample type (PBMC).
    • Date.
  5. Place cryovials into a pre-cooled controlled-rate freezing container (e.g. Mr Frosty) and transfer to a −70 °C or −80 °C freezer.
  6. After at least overnight freezing, move cryovials to liquid nitrogen for long-term storage.

Buffers Required

Full composition, preparation, storage, and safety information for each buffer lives in its own linked buffer document — only a concise per-buffer summary is reproduced here, generated automatically from that document.

R0 Medium (Serum-free RPMI)

Component Final concentration / amount
RPMI 1640 to 500 mL (serum-free, no additives)
  • Final volume: 500 mL
  • Preparation note: Optional: add 1% (v/v) Pen/Strep (100x stock) only if sterility support is explicitly required.
  • Storage: 4C, protected from light; 4-6 weeks unopened, 2-4 weeks after opening; do not freeze.
  • Caveat: Serum-free by design - do not add FCS; serum interferes with Ficoll density gradient separation and interface formation.

Full composition, preparation steps, storage, and safety information: BUF-R0-MED.

R10 Medium (RPMI + 10% FCS)

Component Final concentration / amount
RPMI 1640 to 500 mL
Fetal calf serum (FCS) 10% (v/v)
Penicillin/Streptomycin 1% (v/v)
  • Final volume: 500 mL
  • Preparation note: Gently invert to mix; do not vortex.
  • Storage: 4C, protected from light; use within 4 weeks; do not freeze.

Full composition, preparation steps, storage, and safety information: BUF-R10-MED.

2x Freezing Medium

Component Final concentration / amount
RPMI 1640 (R0) base medium (7 mL per 10 mL batch)
Fetal calf serum 10% (v/v)
DMSO (cell-grade) 20% (v/v)
  • Final volume: 10 mL (2x concentrate; example batch, scale as needed)
  • Preparation note: Mix gently by inversion; do not vortex. Keep on ice until use.
  • Storage: Use fresh on day of preparation; do not store; discard any unused buffer.
  • Caveat: DMSO is toxic at room temperature - keep the 2x mix on ice and mix with cells immediately after preparation. Final working freezing medium (after 1:1 mix with cells) contains 10% DMSO.

Full composition, preparation steps, storage, and safety information: BUF-FREEZE-MIX.

Materials

Reagents

Reagent Supplier Cat. # Notes
Ficoll-Paque or equivalent density medium Cytiva / other – Density gradient for PBMC isolation
RPMI 1640 Various – Base for R0 and R10 media
Fetal calf serum (FCS), heat-inactivated Various – 10 % v/v in R10, 10 % v/v in freezing medium
Penicillin/Streptomycin Various – 1 % v/v in R10
DMSO, cell culture grade Various – 20 % in 2× freezing medium; 10 % final in cell suspension
PBS, sterile, 1× (optional) Various – For additional washes if required
Trypan blue or viability dye Various – For counting and assessing viability

Disposables

Item Specification
50 mL conical tubes Sterile, for blood and Ficoll
10 mL round-bottom tubes Sterile, for PBMC collection
Cryovials Suitable for liquid nitrogen storage
Serological pipettes (5–25 mL) For layering and media handling
Pipette tips Sterile (10 µL, 200 µL, 1000 µL)
Transfer pipettes For harvesting PBMC interface
Biohazard waste containers For blood-contaminated disposables

Equipment

Equipment Specification / Notes
Benchtop centrifuge For 50 mL and 10 mL tubes; adjustable rcf
Class II biological safety cabinet For handling human blood and PBMCs
Controlled-rate freezing container e.g. Mr Frosty, for −70/−80 °C freezing
−70 °C or −80 °C freezer For initial freezing
Liquid nitrogen storage system For long-term storage
Hemocytometer or automated cell counter For PBMC counting

Troubleshooting

Problem Possible cause Suggested solution
Poor PBMC layer formation Blood and Ficoll mixed; incorrect centrifuge settings Carefully overlay blood; verify 450 g; reduce brake to minimal
Low PBMC yield Interface harvested too shallow or too deep Practice aspirating only the fluffy interface; avoid Ficoll and pellet
High granulocyte or RBC contamination Interface disturbed; Ficoll aspiration Harvest more gently; leave a thin Ficoll layer above the pellet
PBMC clumping High cell concentration; extended room temperature time Gently resuspend; consider DNase during processing; shorten handling time
Reduced viability after thawing Inadequate freezing rate or DMSO handling Use controlled-rate freezing; minimize time with DMSO at room temperature
Loss of cells during washes Pellets disturbed when decanting Leave a small volume above the pellet; decant carefully; use pipette to remove residual supernatant

Safety (brief)

  • Treat all human blood and PBMCs as potentially infectious material.
  • Work in a Class II biological safety cabinet and follow institutional BSL2 procedures.
  • Wear appropriate PPE (lab coat, gloves, eye protection) at all times when handling blood and PBMCs.
  • Dispose of blood-contaminated materials (tips, tubes, pipettes, Ficoll waste) as biohazardous waste.
  • Handle DMSO and cryogenic materials (e.g. liquid nitrogen) according to institutional chemical and cryogen safety guidelines.

Version history

Version Date Author Changes
v1.0 2025-11-21 Dillon Corvino First Quarto protocol version for PBMC isolation by Ficoll gradient.
v1.1 2026-09-18 Dillon Corvino Replaced # Buffers used (bare library(tidyverse), leaked R package-startup warnings) with an auto-generated # Buffers Required section; moved it from after Materials to before Materials. Fixed stale buffer-ID references BUF-GEN-R0-MED-001 -> BUF-R0-MED, BUF-GEN-R10-MED-001 -> BUF-R10-MED, BUF-GEN-FREEZE-MIX-001 -> BUF-FREEZE-MIX